BOSTONGENE CORP has a total of 48 patent applications. It increased the IP activity by 2900.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets computer technology, biotechnology and environmental technology are EGENOMICS INC, NAVIGENICS INC and UBIOME INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 22 | |
#2 | Australia | 4 | |
#3 | Canada | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | EPO (European Patent Office) | 3 | |
#6 | United Kingdom | 3 | |
#7 | Israel | 3 | |
#8 | China | 2 | |
#9 | Singapore | 2 | |
#10 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Computer technology | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Measurement | |
#5 | Organic fine chemistry | |
#6 | Pharmaceuticals |
# | Name | Total Patents |
---|---|---|
#1 | Bagaev Alexander | 40 |
#2 | Frenkel Feliks | 38 |
#3 | Ataullakhanov Ravshan | 37 |
#4 | Kotlov Nikita | 23 |
#5 | Artomov Maksym | 8 |
#6 | Ravshan Ataullakhanov | 3 |
#7 | Lozinsky Yaroslav | 3 |
#8 | Alexander Bagaev | 3 |
#9 | Miheecheva Natalia | 3 |
#10 | Nuzhdina Ekaterina | 3 |
Publication | Filing date | Title |
---|---|---|
US2021005283A1 | Techniques for bias correction in sequence data | |
AU2018284077A1 | Systems and methods for identifying responders and non-responders to immune checkpoint blockade therapy | |
CA3056212A1 | Construction and methods of use of a therapeutic cancer vaccine library comprising fusion-specific vaccines |